Yahui Investment’s new dual-currency fund completed over-raise

Visit the original URL

Alwin Capital recently closed a new phase of dual-currency fund, and the fund achieved over-raise, with a scale of over 2 billion yuan.

The RMB investors of this fund include large domestic funds of funds, government guidance funds, industry leading companies, insurance and banks and other financial institutions; based on the high recognition of Yahui Investment, the reinvestment rate of its RMB LP exceeds 50%. The US dollar investors of this fund include well-known market-oriented funds of funds, large asset management companies at home and abroad, industry investors and family offices.

Yahui Investment is a professional investment fund focusing on the frontier fields of life sciences. The founding team of Yahui Investment has been deeply involved in China’s pharmaceutical industry for 20 years. It has both industrial and financial backgrounds and rich experience in investment research. In the past few years, based on professional research, taking scientific lines as clues, adhering to a sound investment research system and mature portfolio management, Yahui Investment has carried out a systematic layout in the frontier fields of China’s life sciences, in gene editing, nucleic acid drugs , cell therapy, molecular diagnostics and other frontier fields of life sciences have cultivated many important leading companies; at the same time, in the track of the intersection of innovative technology and life sciences, it has invested in a number of star projects with keen investment judgment.

The corporate ecology of Yahui Investment in the field of medical and pharmaceutical innovation in China has begun to take shape. From the in-depth development of upstream and downstream to the horizontal extension of multi-platform technology, Yahui Investment has formed a profound competitive advantage in project acquisition, portfolio construction and post-investment empowerment. Yahui Investment has increasingly become a professional and dedicated investment force in China’s life science field.

image.png

media coverage

Investment Community Titanium Media Investment China Network
Related events

This article is reproduced from: https://readhub.cn/topic/8jECS081UxZ
This site is for inclusion only, and the copyright belongs to the original author.